Omeros Corp (OMER)
3.035
-0.04
(-1.30%)
USD |
NASDAQ |
Apr 24, 16:00
3.035
0.00 (0.00%)
After-Hours: 20:00
Omeros Cash from Financing (TTM): -106.08M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -106.08M |
September 30, 2023 | -1.782M |
June 30, 2023 | 123.54M |
March 31, 2023 | 123.70M |
December 31, 2022 | 124.25M |
September 30, 2022 | 124.09M |
June 30, 2022 | -0.27M |
March 31, 2022 | 0.684M |
December 31, 2021 | 6.319M |
September 30, 2021 | 6.966M |
June 30, 2021 | 178.94M |
March 31, 2021 | 177.93M |
December 31, 2020 | 174.53M |
September 30, 2020 | 231.17M |
June 30, 2020 | 61.78M |
March 31, 2020 | 63.24M |
December 31, 2019 | 60.70M |
September 30, 2019 | 34.31M |
June 30, 2019 | 34.97M |
March 31, 2019 | 80.36M |
December 31, 2018 | 81.05M |
September 30, 2018 | 52.07M |
June 30, 2018 | 116.73M |
March 31, 2018 | 74.44M |
December 31, 2017 | 75.00M |
Date | Value |
---|---|
September 30, 2017 | 82.69M |
June 30, 2017 | 51.78M |
March 31, 2017 | 68.18M |
December 31, 2016 | 68.70M |
September 30, 2016 | 69.81M |
June 30, 2016 | 30.56M |
March 31, 2016 | 7.783M |
December 31, 2015 | 86.83M |
September 30, 2015 | 77.72M |
June 30, 2015 | 79.78M |
March 31, 2015 | 82.28M |
December 31, 2014 | 50.86M |
September 30, 2014 | 55.51M |
June 30, 2014 | 55.26M |
March 31, 2014 | 70.86M |
December 31, 2013 | 21.65M |
September 30, 2013 | 21.10M |
June 30, 2013 | 51.93M |
March 31, 2013 | 34.37M |
December 31, 2012 | 32.97M |
September 30, 2012 | 27.18M |
June 30, 2012 | -3.579M |
March 31, 2012 | -2.09M |
December 31, 2011 | 9.486M |
September 30, 2011 | 11.27M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-106.08M
Minimum
Dec 2023
231.17M
Maximum
Sep 2020
74.68M
Average
61.78M
Median
Jun 2020
Cash from Financing (TTM) Benchmarks
Aspira Womens Health Inc | 5.216M |
Ardelyx Inc | 146.30M |
Panbela Therapeutics Inc | 26.14M |
Ensysce Biosciences Inc | 8.756M |
MAIA Biotechnology Inc | 9.271M |